Axon Enterprise, Inc. (NASDAQ:AXON) Shares Purchased by Schaper Benz & Wise Investment Counsel Inc. WI

Schaper Benz & Wise Investment Counsel Inc. WI lifted its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,302 shares of the biotechnology company’s stock after acquiring an additional 164 shares during the quarter. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Axon Enterprise were worth $10,283,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Prestige Wealth Management Group LLC grew its position in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise in the 4th quarter worth approximately $40,000. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise in the 3rd quarter worth approximately $41,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise in the 4th quarter worth approximately $45,000. Finally, Planning Capital Management Corp grew its position in shares of Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on AXON shares. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price for the company. in a research report on Thursday, February 20th. The Goldman Sachs Group raised their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Barclays set a $726.00 price target on Axon Enterprise and gave the stock an “overweight” rating in a report on Thursday, February 27th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Finally, Northland Securities raised their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $587.38.

Axon Enterprise Trading Up 5.4 %

Shares of Axon Enterprise stock opened at $526.40 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market cap of $40.33 billion, a price-to-earnings ratio of 136.02, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The business has a fifty day simple moving average of $599.42 and a 200-day simple moving average of $529.53. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99.

Insider Activity

In other news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,146 shares of company stock worth $3,262,847 over the last 90 days. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.